Ground News

News from ILCN.org (ILCN/WCLC)

Your destination for news from ILCN.org (ILCN/WCLC). See how ILCN.org (ILCN/WCLC)’s media bias impacts the breaking news stories of today.

Overall, we’ve indexed 20 stories from ILCN.org (ILCN/WCLC) over the past 3 months.

Ground News rates ILCN.org (ILCN/WCLC)’s media bias as unknown. . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

If you want to know if ILCN.org (ILCN/WCLC) is credible or reliable, look no further. We rank ILCN.org (ILCN/WCLC) as Unknown factuality. Find out more about our methodology here.

Information about ILCN.org (ILCN/WCLC)

Where is ILCN.org (ILCN/WCLC) located?ILCN.org (ILCN/WCLC)'s Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top ILCN.org (ILCN/WCLC) News

Cancer · United States

Advances in Radiation Improve Precision in Brain Cancer Therapy

The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.See the Story

Dallas, Texas · Dallas

A 40-Year Chase in SCLC: Where We’ve Been and Where We’re Going - ILCN.org (ILCN/WCLC)

The Closing Keynote at the 2025 Hot Topics in Small Cell Lung Cancer (SCLC) centered around four decades of research in the field. Anish Thomas, MBBS, MD, began by inviting attendees to be inspired by the vision and scientific clarity that has defined the past 40 years of SCLC research, before introducing the keynote speaker, John D. Minna, MD. John D. Minna, MD This session and other meeting coverage is available on demand via Lung Cancer 360 …Read Article

Health Canada · Canada

In Brief for May 14, 2025 - ILCN.org (ILCN/WCLC)

Health Canada has approved the combination of pembrolizumab with chemotherapy for first-line treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM). This represents Canada’s first approved pembrolizumab-chemotherapy combination regimen for patients with MPM. The decision was based on findings from the IND.227/KEYNOTE-483 trial, which revealed statistically significant improvements in overall survival (OS), overall …Read Article

News from ILCN.org (ILCN/WCLC)

News from ILCN.org (ILCN/WCLC)

Information about ILCN.org (ILCN/WCLC)

Media Bias Ratings

Factuality

Ownership

Top ILCN.org (ILCN/WCLC) News

Advances in Radiation Improve Precision in Brain Cancer Therapy

A 40-Year Chase in SCLC: Where We’ve Been and Where We’re Going - ILCN.org (ILCN/WCLC)

In Brief for May 14, 2025 - ILCN.org (ILCN/WCLC)

Similar News Topics

Topics Most Covered by ILCN.org (ILCN/WCLC)

Sources Covering Similar Topics

Breaking News Topics Related to ILCN.org (ILCN/WCLC)

Top ILCN.org (ILCN/WCLC) News

Advances in Radiation Improve Precision in Brain Cancer Therapy

A 40-Year Chase in SCLC: Where We’ve Been and Where We’re Going - ILCN.org (ILCN/WCLC)

In Brief for May 14, 2025 - ILCN.org (ILCN/WCLC)

Results From the AENEAS2 Trial Point to a New Frontline Treatment Option for NSCLC - ILCN.org (ILCN/WCLC)

Beamion LUNG-01 Trial Results Support Zongertinib’s Potential as a First-Line Therapy - ILCN.org (ILCN/WCLC)

A Real Tail in These Curves: A Look at Advances and Future Directions in SCLC - ILCN.org (ILCN/WCLC)

Up in the Air: A Patient’s Perspective on Navigating Lung Cancer Treatment During One of the Most Devastating Wildfires in US History - ILCN.org (ILCN/WCLC)

Overview of Study Design of the COCOON Trial

Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence - ILCN.org (ILCN/WCLC)

From Grief to Global Change: How the STARS Program Empowers Advocates to Drive Lung Cancer Research - ILCN.org (ILCN/WCLC)

Foritinib Gains Momentum in China for ALK-positive NSCLC - ILCN.org (ILCN/WCLC)

Breaking News Topics Related to ILCN.org (ILCN/WCLC)

Similar News Topics